NCT02794077
- Conditions
- Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Undifferentiated Carcinoma
- Locations
-
Not specified
Clinical trial condition
Recurrent Nasopharyngeal Undifferentiated Carcinoma
Explore clinical trials studying Recurrent Nasopharyngeal Undifferentiated Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Recurrent Nasopharyngeal Undifferentiated Carcinoma trial results
Active, Not Recruiting
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
NCT00336063
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +8 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Chinese University of Hong Kong-Prince of Wales Hospital Shatin, Hong Kong
- National Cancer Center Hospital Tokyo, Japan
- National University Hospital Singapore Singapore